Fig. 1From: Vitamin D receptor activator and prevention of cardiovascular events in hemodialysis patients—rationale and design of the Japan Dialysis Active Vitamin D (J-DAVID) trialDesign of the J-DAVID study. IC informed consent, S screening, R randomization, M months, SAEs serious adverse eventsBack to article page